Intentions of public school teachers in British Columbia, Canada to receive a COVID-19 vaccine.

COVID-19 Health policy Infectious disease Public health Vaccines

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 01 03 2021
revised: 27 04 2021
accepted: 23 06 2021
pubmed: 6 7 2021
medline: 6 7 2021
entrez: 5 7 2021
Statut: ppublish

Résumé

To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada. A population-wide cross-sectional online survey from August to November 2020 asked all BC public school teachers with an available email address how likely they were to receive a COVID-19 vaccine. Two multivariable logistic regression models explored separately sociodemographic and vaccine hesitancy predictors for intention to receive a COVID-19 vaccine. A total of 5,076 teachers participated. The majority, 89.7%, reported they were likely or very likely to accept a COVID-19 vaccine. In multivariable regression, sociodemographic predictors of intention to be vaccinated included being male, having an educational background in science or engineering, and using reliable information sources on vaccination such as public health and health care providers. Teachers who reported lower levels of vaccine hesitancy, higher general vaccine knowledge, and belief that COVID-19 was a serious illness were more likely to intend to receive a COVID-19 vaccine. A high proportion of public-school teachers in BC intend to receive a COVID-19 vaccine. Continued monitoring of vaccine intentions will be important to inform public health vaccine implementation.

Sections du résumé

BACKGROUND BACKGROUND
To control the COVID-19 pandemic high vaccine acceptability and uptake will be needed. Teachers represent a priority population to minimize social disruption and ensure continuity in education, which is vital for the well-being and healthy development of youth during the pandemic. The objective of this analysis was to measure public school teachers' intentions to receive a COVID-19 vaccine in British Columbia (BC), Canada.
METHODS METHODS
A population-wide cross-sectional online survey from August to November 2020 asked all BC public school teachers with an available email address how likely they were to receive a COVID-19 vaccine. Two multivariable logistic regression models explored separately sociodemographic and vaccine hesitancy predictors for intention to receive a COVID-19 vaccine.
RESULTS RESULTS
A total of 5,076 teachers participated. The majority, 89.7%, reported they were likely or very likely to accept a COVID-19 vaccine. In multivariable regression, sociodemographic predictors of intention to be vaccinated included being male, having an educational background in science or engineering, and using reliable information sources on vaccination such as public health and health care providers. Teachers who reported lower levels of vaccine hesitancy, higher general vaccine knowledge, and belief that COVID-19 was a serious illness were more likely to intend to receive a COVID-19 vaccine.
CONCLUSION CONCLUSIONS
A high proportion of public-school teachers in BC intend to receive a COVID-19 vaccine. Continued monitoring of vaccine intentions will be important to inform public health vaccine implementation.

Identifiants

DOI: 10.1016/j.jvacx.2021.100106 PMID: 34222854 PMC: PMC8240436
pubmed: 34222854
doi: 10.1016/j.jvacx.2021.100106
pii: S2590-1362(21)00023-1
pmc: PMC8240436
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100106

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

C Sarai Racey (CS)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC, Canada.

Robine Donken (R)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC, Canada.
Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Imogen Porter (I)

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Arianne Albert (A)

Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC, Canada.

Julie A Bettinger (JA)

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Jennifer Mark (J)

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Lizl Bonifacio (L)

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Meena Dawar (M)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Vancouver Costal Health Authority, Vancouver, BC, Canada.

Mike Gagel (M)

Northern Health Authority, Prince George, BC, Canada.

Rakel Kling (R)

Northern Health Authority, Prince George, BC, Canada.

Silvina Mema (S)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Interior Health Authority, Kelowna, BC, Canada.

Hana Mitchell (H)

Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
BC Children's Hospital Research Institute, Vancouver, BC, Canada.

Ian Roe (I)

BC Centre for Disease Control, Vancouver, BC, Canada.

Gina Ogilvie (G)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC, Canada.
BC Centre for Disease Control, Vancouver, BC, Canada.

Manish Sadarangani (M)

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Classifications MeSH